Patents

Patented Vaccines and Diagnostics for Diabetes and Celiac Disease

Vactech is the sole owner of the patents and patent applications covering the preventive type 1 diabetes vaccine. In addition, Vactech’s patents cover antiviral drugs and diagnostic assays for type 1 diabetes enabling the company to build a product family around diabetes prevention and cure. The IPR portfolio includes in addition international patents covering virus-based products to treat and prevent celiac disease.

Strong Patents Protecting Global Health Innovations

Vactech holds full ownership of a broad international patent portfolio protecting innovations in type 1 diabetes prevention, diagnostics, and antiviral treatments. As the sole owner of patents for the preventive type 1 diabetes vaccine, as well as related antiviral drugs and diagnostic assays, Vactech is uniquely positioned to develop and commercialize comprehensive solutions for diabetes prevention and care. The portfolio also includes international patents for virus-based products to treat and prevent celiac disease.

Ask for more

“Our robust international patent portfolio underscores Vactech's commitment to pioneering global health solutions. As the exclusive holder of patents for our groundbreaking preventive vaccine for type 1 diabetes, alongside related diagnostics and antiviral therapies, we are uniquely positioned to lead in diabetes prevention and care. Protecting our innovations ensures we can continue to advance transformative treatments, addressing critical health challenges worldwide.” Tero Välimaa – CEO, Ph.D

Comprehensive Intellectual Property Rights (IPR)

Vactech’s strong international patent portfolio spans key markets—including the EU, USA, China, India, and Japan—covering advanced technologies in preventive vaccines, diagnostic assays, and antiviral therapies for type 1 diabetes and celiac disease. This comprehensive IPR foundation enables us to deliver innovative and transformative healthcare solutions worldwide.

Career Opportunities

At Vactech, Innovation Meets Impact.
Join Us in Reshaping Global Health.

Join our team

About Vactech

Vactech is a company with a pipeline of product candidates focused on type 1 diabetes, celiac disease, and diagnostics. The primary focus of our research and product development is to unravel and treat the complexities of immune-mediated diseases and enteroviruses.